SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Glucose Health, Inc. – ‘S-1’ on 5/31/22 – ‘EX-10.7’

On:  Tuesday, 5/31/22, at 7:34pm ET   ·   As of:  6/1/22   ·   Accession #:  1477932-22-4038   ·   File #:  333-265335

Previous ‘S-1’:  ‘S-1/A’ on 4/23/09   ·   Next:  ‘S-1/A’ on 8/5/22   ·   Latest:  ‘S-1/A’ on 1/9/23   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/01/22  Glucose Health, Inc.              S-1         5/31/22   63:17M                                    Discount Edgar/FA

Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   1.15M 
 2: EX-2.1      Plan and Agreement of Merger                        HTML     30K 
 3: EX-2.2      Certificate of Merger                               HTML     56K 
 4: EX-3.1      Articles of Conversion                              HTML     16K 
 5: EX-3.2      Certificate of Conversion                           HTML     27K 
 6: EX-3.3      Amended and Restated Certificate of Incorporation   HTML     52K 
 7: EX-3.4      Amended and Restated Bylaws                         HTML     63K 
 8: EX-3.5      Certificate of Correction                           HTML     19K 
 9: EX-10.2     Series B Preferred Stock Purchase Agreemen          HTML     81K 
10: EX-10.3     Series C Preferred Stock Purchase Agreement         HTML     77K 
11: EX-10.4     Series D Preferred Stock Purchase Agreement         HTML     82K 
12: EX-10.5     Series E Preferred Stock Purchase Agreement         HTML    100K 
13: EX-10.6     Convertible Promissory Note                         HTML     34K 
14: EX-10.7     Services Agreement                                  HTML     25K 
15: EX-10.8     Consulting Agreement                                HTML     41K 
16: EX-23.1     Consent of Expert or Counsel                        HTML     16K 
19: EX-FILING FEES  Filling Fee Table                               HTML     35K 
17: EX-99.4     Consent                                             HTML     17K 
18: EX-99.5     Consent                                             HTML     17K 
25: R1          Cover                                               HTML     47K 
26: R2          Balance Sheets                                      HTML    110K 
27: R3          Balance Sheets (Parenthetical)                      HTML     53K 
28: R4          Statements of Operations                            HTML     97K 
29: R5          Statements of Shareholders' Equity                  HTML     68K 
30: R6          Statements of Cash Flows                            HTML     95K 
31: R7          Organization and Basis of Presentation              HTML     30K 
32: R8          Summary of Significant Accounting Policies          HTML     82K 
33: R9          Stockholders Equity                                 HTML     85K 
34: R10         Notes Payable                                       HTML     32K 
35: R11         Federal Income Tax                                  HTML     51K 
36: R12         Commitments Contingencies                           HTML     22K 
37: R13         REVENUE CONCENTRATION and ACCOUNTS RECEIVABLE       HTML     20K 
38: R14         Recovery of Retailer Chargebacks                    HTML     20K 
39: R15         Related Party Transactions                          HTML     22K 
40: R16         Subsequent Events                                   HTML     24K 
41: R17         Summary of Significant Accounting Policies          HTML    110K 
                (Policies)                                                       
42: R18         Summary of Significant Accounting Policies          HTML     31K 
                (Tables)                                                         
43: R19         Stockholders Equity (Tables)                        HTML     57K 
44: R20         Federal Income Tax (Tables)                         HTML     44K 
45: R21         Organization and Basis of Presentation (Details     HTML     48K 
                Narrative)                                                       
46: R22         Summary of Significant Accounting Policies          HTML     24K 
                (Details)                                                        
47: R23         Summary of Significant Accounting Policies          HTML     38K 
                (Details Narrative)                                              
48: R24         Stockholders Deficit (Details)                      HTML     42K 
49: R25         Stockholders Deficit (Details 1)                    HTML     32K 
50: R26         Stockholders Deficit (Details Narrative)            HTML     75K 
51: R27         Notes Payable (Details Narrative)                   HTML     70K 
52: R28         Federal Income Tax (Details)                        HTML     25K 
53: R29         Federal Income Tax (Details 1)                      HTML     28K 
54: R30         Federal Income Tax (Details Narrative)              HTML     24K 
55: R31         REVENUE CONCENTRATION and ACCOUNTS RECEIVABLE       HTML     27K 
                (Details Narrative)                                              
56: R32         Recovery of Retailer Chargebacks (Details           HTML     19K 
                Narrative)                                                       
57: R33         Related Party Transactions (Details Narrative)      HTML     23K 
58: R34         Subsequent Events (Details Narrative)               HTML     54K 
61: XML         IDEA XML File -- Filing Summary                      XML     90K 
59: XML         XBRL Instance -- gluc_s1_htm                         XML    949K 
60: EXCEL       IDEA Workbook of Financial Reports                  XLSX     58K 
22: EX-101.CAL  XBRL Calculations -- gluc-20220331_cal               XML    105K 
24: EX-101.DEF  XBRL Definitions -- gluc-20220331_def                XML    337K 
21: EX-101.LAB  XBRL Labels -- gluc-20220331_lab                     XML    553K 
23: EX-101.PRE  XBRL Presentations -- gluc-20220331_pre              XML    468K 
20: EX-101.SCH  XBRL Schema -- gluc-20220331                         XSD    116K 
62: JSON        XBRL Instance as JSON Data -- MetaLinks              215±   282K 
63: ZIP         XBRL Zipped Folder -- 0001477932-22-004038-xbrl      Zip    605K 


‘EX-10.7’   —   Services Agreement


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  gluc_ex107.htm  
 C: 

EXHIBIT 10.7

  

SERVICES AGREEMENT

 

THIS AGREEMENT, is made as of April 1, 2022, between Glucose Health, Inc. (“Company”) and BTB Management Company (“Consultant”) and super cedes a previous agreement dated July 1, 2021, between the Company and Murray Fleming, and all provisions set forth in this Agreement shall govern.  

 

1.

SERVICES. Consultant agrees to perform the services of management of corporate operations. Principal of Consultant agrees to serve as CEO and CFO of Company.

 

 

2.

RATE OF PAYMENT. $8,000.00 per month, ($24,000.00 per quarter) is payable to Consultant upon execution of this agreement.

 

 

3.

BONUS COMPENSATION FOR PERFORMANCE. An additional $100,000 in bonus compensation is payable or achievement of any combination of the following performance metrics.

 

 

a.

Revenue: $50,000 bonus upon achieving $1 million Revenue.

 

b.

Stockholder Equity: $25,000 bonus upon achieving $2 million Stockholder Equity.

 

c.

Gross Margin: $10,000 for achieving 35% Gross Margin in a quarterly period.

 

d.

Sales: $15,000 upon securing placement of a national or large regional retailer (upon receipt of first invoice payment).

 

 

4.

TERMS FOR SERVICES. This agreement renews quarterly until terminated by either party.   

 

 

 

 

5.

CONFIDENTIAL INFORMATION. Each party hereto (“Such Party”) shall hold in trust for the other party hereto (“Such Other Party”) and shall not disclose to any non-party to the Agreement, any confidential information of Such Other Party. Confidential information is information which relates to Such Other Party’s research, development, trade secrets or business affairs, but does not include information which is generally known or easily ascertainable by non-parties of ordinary skill in computer systems design and programming.

 

 

 

 

 

The Consultant hereby acknowledges that during the performance of this contract, the Consultant may learn or receive confidential Company information and therefore Consultant hereby confirms that all such information relating to the Company’s business will be kept confidential by the Consultant, except to the extent that such information is required to be divulged to the Consultant’s clerical or support staff or associates in order to enable Consultant to perform Consultant’s contract obligation.

 

 

 

 

6.

INDEPENDENT CONTRACTOR.  Consultant is an independent contractor. Consultant is not an employee, agent, joint venture or partner of Company. Nothing shall be interpreted as creating an employment relationship. Consultant shall have control of the manner and means by which its services are provided to Company. CONSULTANT IS SOLELY LIABLE FOR ANY FEDERAL AND STATE INCOME AND WITHHOLDING TAXES, UNEMPLOYMENT TAXES, FICA TAXES, AND WORKER'S COMPENSATION PAYMENTS AND PREMIUMS APPLICABLE TO THIS AGREEMENT.

   

 

1

 

   

 

7.

COMPLETE AGREEMENT. This Agreement contains the entire agreement between the parties hereto with respect to the matters covered herein.  No other agreements, representations, warranties or other matters, oral or written, purportedly agreed to or represented by or on behalf of the Consultant by any of its agents, or contained in any sales materials or brochures, shall be deemed to bind the parties hereto with respect to the subject matter hereof. The Company and Consultant acknowledge that they are entering into this Agreement solely on the basis of the representations contained herein.

 

 

 

 

8.

GENERAL PROVISIONS.  This Agreement is binding upon the parties hereto and their respective successors, assignees and personal representatives. This Agreement shall be interpreted, construed and governed in accordance with the laws of the State of Nevada. This Agreement may be executed in counterparts and may be executed by telefax signature, which shall be valid and binding as original signatures for all purposes (evidentiary or otherwise).

  

IN WITNESS WHEREOF, the parties hereto, have signed this Agreement, as of the date first above written:

 

 

FOR GLUCOSE HEALTH, INC.

 

 

 

 

 

 

Per:  

/s/ Murray Fleming

 

 

 

Murray Fleming, CEO/CFO

 

 

 

 

 

 

FOR BTB MANAGEMENT COMPANY

 

 

 

 

 

 

Per:

/s/ Murray Fleming

 

 

 

Murray Fleming, Principal

 

 

 

2

 


Dates Referenced Herein

This ‘S-1’ Filing    Date    Other Filings
Filed as of:6/1/22None on these Dates
Filed on:5/31/22
4/1/22
7/1/21
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/09/23  Glucose Health, Inc.              S-1/A                 59:7M                                     Discount Edgar/FA
 9/06/22  Glucose Health, Inc.              S-1/A       9/02/22   49:5.9M                                   Discount Edgar/FA
 8/05/22  Glucose Health, Inc.              S-1/A                 49:5.7M                                   Discount Edgar/FA
Top
Filing Submission 0001477932-22-004038   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 5:31:17.1am ET